Cargando…
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex
Damage and disease of nerves activates the complement system. We demonstrated that activation of the terminal pathway of the complement system leads to the formation of the membrane attack complex (MAC) and delays regeneration in the peripheral nervous system. Animals deficient in the complement com...
Autores principales: | Gytz Olesen, Heidi, Michailidou, Iliana, Zelek, Wioleta M., Vreijling, Jeroen, Ruizendaal, Patrick, de Klein, Ferry, Marquart, J. Arnoud, Kuipers, Thomas B., Mei, Hailiang, Zhang, Yuchun, Ahasan, Muhammad, Johnson, Krista K., Wang, Yi, Morgan, B. Paul, van Dijk, Marcus, Fluiter, Kees, Andersen, Gregers Rom, Baas, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643903/ https://www.ncbi.nlm.nih.gov/pubmed/35551129 http://dx.doi.org/10.1159/000524587 |
Ejemplares similares
-
The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22
por: Michailidou, Iliana, et al.
Publicado: (2023) -
Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis
por: Michailidou, Iliana, et al.
Publicado: (2018) -
Editorial: Complement in nervous system disease
por: Michailidou, Iliana, et al.
Publicado: (2023) -
M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator
por: Bahia El Idrissi, Nawal, et al.
Publicado: (2015) -
Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury
por: van Erp, Inge A. M., et al.
Publicado: (2022)